Market Overview:
The global metoclopramide market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of gastrointestinal disorders, increasing awareness about metoclopramide and its benefits, and growing demand for injectable formulations of metoclopramide. However, the high cost of treatment is expected to restrain the growth of the market during the forecast period. Based on type, oral formulations accounted for a major share of the global metoclopramide market in 2017. This can be attributed to their easy availability and low cost as compared to other formulations. Injection forms are expected to grow at a higher CAGR during the forecast period due their advantages such as improved patient compliance and reduced incidence of adverse effects as compared with oral forms.
Product Definition:
Metoclopramide is a medication that is used to treat various gastrointestinal disorders. It works by speeding up the movement of food through the stomach and intestines. Metoclopramide is also used to increase milk production in nursing mothers.
Oral:
Oral is a form of drug administration which involves the use of drugs in front of the patient's mouth. The most common route of drug administration is by oral ingestion. Other routes include transdermal, intravenous and inhalation (by nebulizer).
Injection:
Injection is a drug form that contains the active ingredient Metoclopramide. It is used to treat nausea and vomiting caused due to motion or position changes, cancer chemotherapy, pregnancy, and other diseases. The drug works by increasing the flow of chloride ions (Cl-), which reduces the acid production in the stomach.
Application Insights:
Based on the application, the global metoclopramide market is segmented into nausea, migraine and gastroparesis. The nausea segment dominated the overall market in terms of revenue in 2017 owing to increasing prevalence of this condition coupled with growing awareness about its treatment. According to a survey conducted by National Center for Biotechnology Information (NCBI) in 2018, out of total population aged 60 years and above 1% reported experiencing nausea daily while 0.5% reported frequent nauseous feeling. Thus, increasing incidence rate coupled with growing awareness about treatment is expected to drive demand over the forecast period (2017-2030).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing prevalence of gastric and duodenal ulcers, rising preference for non-invasive surgeries, and growing awareness about drug safety & efficacy. In addition, high healthcare expenditure levels in this region are anticipated to boost metoclopramide demand during the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing to improving economic conditions and a large aging population that suffer from chronic diseases such as Parkinson’s disease or Alzheimer's disease (AD).
Growth Factors:
- Increasing prevalence of gastrointestinal disorders: The global prevalence of gastrointestinal disorders is increasing due to the changing lifestyle and dietary habits. This is expected to drive the demand for metoclopramide in the coming years.
- Growing awareness about metoclopramide benefits: There is a growing awareness among healthcare professionals and patients about the benefits of metoclopramide therapy, which is expected to boost its demand in the near future.
- Rising number of clinical studies on metoclopramide: A large number of clinical studies are being conducted on metoclopramide across the world, which is likely to create new opportunities for this market in the coming years.
- Launch of novel formulations: Several pharmaceutical companies are launching novel formulations and dosage forms of metoclopramide, which is likely to increase its adoption in various regions worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Metoclopramide Market Research Report
By Type
Oral, Injection
By Application
Nausea, Migraine, Gastroparesis
By Companies
Teva, Sanofi, Astellas, Adwya, Biofarma, Apotex, Novartis, ASKA Seiyaku Asuka, Yang Sheng, Meda Pharma, Johnson and Johnson, GSK, Alkaloid Pharmaceuticals, Teuto Brasileiro, Mylan, EU-Pharma, Le Vet, Omega Laboratories, Orion Pharma, Pfizer, Wockhardt, Amneal Pharmaceuticals, Nidda, Ceva Sante Animale
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Metoclopramide Market Report Segments:
The global Metoclopramide market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nausea, Migraine, Gastroparesis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Sanofi
- Astellas
- Adwya
- Biofarma
- Apotex
- Novartis
- ASKA Seiyaku Asuka
- Yang Sheng
- Meda Pharma
- Johnson and Johnson
- GSK
- Alkaloid Pharmaceuticals
- Teuto Brasileiro
- Mylan
- EU-Pharma
- Le Vet
- Omega Laboratories
- Orion Pharma
- Pfizer
- Wockhardt
- Amneal Pharmaceuticals
- Nidda
- Ceva Sante Animale
Highlights of The Metoclopramide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Nausea
- Migraine
- Gastroparesis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metoclopramide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metoclopramide is a medication used to treat nausea and vomiting. It works by blocking the action of stomach acid, which reduces the amount of food that is eaten and vomit produced.
Some of the major companies in the metoclopramide market are Teva, Sanofi, Astellas, Adwya, Biofarma, Apotex, Novartis, ASKA Seiyaku Asuka, Yang Sheng, Meda Pharma, Johnson and Johnson, GSK, Alkaloid Pharmaceuticals, Teuto Brasileiro, Mylan, EU-Pharma, Le Vet, Omega Laboratories, Orion Pharma, Pfizer, Wockhardt, Amneal Pharmaceuticals, Nidda, Ceva Sante Animale.
The metoclopramide market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Metoclopramide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Metoclopramide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Metoclopramide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Metoclopramide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Metoclopramide Market Size & Forecast, 2018-2028
4.5.1 Metoclopramide Market Size and Y-o-Y Growth
4.5.2 Metoclopramide Market Absolute $ Opportunity
Chapter 5 Global Metoclopramide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Metoclopramide Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Metoclopramide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Metoclopramide Market Size Forecast by Applications
6.2.1 Nausea
6.2.2 Migraine
6.2.3 Gastroparesis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Metoclopramide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Metoclopramide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Metoclopramide Analysis and Forecast
9.1 Introduction
9.2 North America Metoclopramide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Metoclopramide Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Metoclopramide Market Size Forecast by Applications
9.10.1 Nausea
9.10.2 Migraine
9.10.3 Gastroparesis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Metoclopramide Analysis and Forecast
10.1 Introduction
10.2 Europe Metoclopramide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Metoclopramide Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Metoclopramide Market Size Forecast by Applications
10.10.1 Nausea
10.10.2 Migraine
10.10.3 Gastroparesis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Metoclopramide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Metoclopramide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Metoclopramide Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Metoclopramide Market Size Forecast by Applications
11.10.1 Nausea
11.10.2 Migraine
11.10.3 Gastroparesis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Metoclopramide Analysis and Forecast
12.1 Introduction
12.2 Latin America Metoclopramide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Metoclopramide Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Metoclopramide Market Size Forecast by Applications
12.10.1 Nausea
12.10.2 Migraine
12.10.3 Gastroparesis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Metoclopramide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Metoclopramide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Metoclopramide Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Metoclopramide Market Size Forecast by Applications
13.10.1 Nausea
13.10.2 Migraine
13.10.3 Gastroparesis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Metoclopramide Market: Competitive Dashboard
14.2 Global Metoclopramide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Sanofi
14.3.3 Astellas
14.3.4 Adwya
14.3.5 Biofarma
14.3.6 Apotex
14.3.7 Novartis
14.3.8 ASKA Seiyaku Asuka
14.3.9 Yang Sheng
14.3.10 Meda Pharma
14.3.11 Johnson and Johnson
14.3.12 GSK
14.3.13 Alkaloid Pharmaceuticals
14.3.14 Teuto Brasileiro
14.3.15 Mylan
14.3.16 EU-Pharma
14.3.17 Le Vet
14.3.18 Omega Laboratories
14.3.19 Orion Pharma
14.3.20 Pfizer
14.3.21 Wockhardt
14.3.22 Amneal Pharmaceuticals
14.3.23 Nidda
14.3.24 Ceva Sante Animale
